CAS RN: 7300-59-6
L-γ-Glutamyl-p-nitroanilide Monohydrate
Product Availability
Choose a grade to view its available package options.
4 package records3 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
|---|---|---|---|---|---|
| Batchno.20251123 | 1g | In stock | Shanghai, Shandong, Guangdong, Hebei | Inquiry | |
| Batchno.20250627 | 200mg | In stock | Shanghai, Shandong, Hebei | Inquiry | |
| Batchno.20250505 | 25g | Out of stock | 5-7 business days | Inquiry | |
| Batchno.20260131 | 5g | In stock | Shanghai, Shandong | Inquiry |
- Product code: SSC-182455
Historical Factory Record
Historical Supply Reference
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
- Pack sizes on record: 1g
- Available purity: ≥98%
- Inventory rows with stock: 0
- Bulk packaging: confirmed by inquiry
Reference Pack Sizes
Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.
| Pack Size | Recorded Purity | Available Qty | Ship From | Inquiry |
|---|---|---|---|---|
| 1g | ≥98% | 0 Out of Stock | Hong Kong | Inquiry |
7300-59-6 / (2S)-2-amino-5-(4-nitroanilino)-5-oxopentanoic acid;hydrate
Basic Information
CAS
7300-59-6
Multi CAS
Yes
Molecular Formula
C11H15N3O6
Molecular Weight
285.250000
Exact Mass
285.096085
InChI
InChI=1S/C11H13N3O5.H2O/c12-9(11(16)17)5-6-10(15)13-7-1-3-8(4-2-7)14(18)19;/h1-4,9H,5-6,12H2,(H,13,15)(H,16,17);1H2/t9-;/m0./s1
InChIKey
HAFIAIPYVFZHSY-FVGYRXGTSA-N
Computed Properties
Structural Parameters
Heavy atom count
20
Aromatic heavy atom count
6
Fraction Csp3
0.27
Rotatable bonds
6
H-bond acceptors
5
H-bond donors
3
Molar refractivity
70.19
TPSA
167.06
LogP / Solubility
WLOGP
-0.1
MLOGP
-0.08
XLogP3
-0.1
Consensus LogP
-0.09
Log S (ESOL)
-1.37
Class (ESOL)
Soluble
Log S (Ali)
-1.83
Class (Ali)
Soluble
Log S (SILICOS-IT)
-2.15
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.53
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
Yes
Synthetic Accessibility
2
